Study Title
ASSET: Acute Lymphoblastic Leukaemia Subtype and Side-Effects from Treatment – Nationwide analysis of severe treatment-related toxicity in childhood leukaemia
Protocol ID
ASSET
Disease (Sub Disease)
Acute Lymphoblastic Leukaemia (ALL)
Diagnosis Stage
Previously treated
Location
NSW, VIC, WA, SA, NZ
Sponsor
Kids Cancer Alliance (KCA)
Links
Trial Status
Open
Sites
The Children's Hospital at Westmead
John Hunter Children's Hospital
Monash Children's Hospital
Perth Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Women's & Children's Hospital
Christchurch Hospital
Starship Hospital
John Hunter Children's Hospital
Monash Children's Hospital
Perth Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Women's & Children's Hospital
Christchurch Hospital
Starship Hospital
Study Type
Registry
Phase
Not applicable
Age Eligibility
up to 18 years
| Study Title | ASSET: Acute Lymphoblastic Leukaemia Subtype and Side-Effects from Treatment – Nationwide analysis of severe treatment-related toxicity in childhood leukaemia |
|---|---|
| Protocol ID | ASSET |
| Disease (Sub Disease) | Acute Lymphoblastic Leukaemia (ALL) |
| Diagnosis Stage | Previously treated |
| Location | NSW / VIC / WA / SA / NZ |
| Sponsor | Kids Cancer Alliance (KCA) |
| Links | http://www.assetstudy.com.au/ |
| Trial Status | Open |
| Trial Open Date | 20/08/2015 |
| Sites | The Children's Hospital at Westmead / John Hunter Children's Hospital / Monash Children's Hospital / Perth Children's Hospital / Sydney Children's Hospital / Royal Children's Hospital / Women's & Children's Hospital / Christchurch Hospital / Starship Hospital |
| Study Type | Registry |
| Phase | Not applicable |
| Age Eligibility | up to 18 years |